AGEN Agenus Inc. Bozor kapitallashuvi
Agenus (AGEN) rivojlanishi kolorektal o'smovlar terapiyasining samaradorligiga va pul oqimini yaratish uchun ishlanmalarning muvaffaqiyatli litsenziyalashiga bog'liq. Bozor kapitalizatsiyasi 0.32 miqdorida belgilangan narx dinamikasi antitanachalar ishlab chiqarish va sinovlari uchun tashqi pudratchilarning jalb qilinganligi bo'yicha ma'lumotlarni to'ldiradi. Moliyaviy barqarorlik kelgusidagi foyda miqdorini belgilovchi hamkorlar to'lovlariga bog'liqlik tufayli cheklangan.
Agenus, Inc (AGEN) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- emitentning balans qiymati statistikasi:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Agenus|AGEN - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Agenus|AGEN - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Agenus, Inc|AGEN - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi Agenus|Tezkor likvidlik koeffitsiyenti agenusbio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
AGEN - Sof foyda|Kelajakdagi foyda Agenus|AGEN - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori Agenus Inc|AGEN - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Agenus, Inc|AGEN - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Agenus|AGEN - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi agenusbio.com|AGEN - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Agenus
Kompaniyaning fundamental tahlili:AGEN (Agenus Inc.)
Agenus immuno-onkologik dori vositalarini ishlab chiqishning ilk bosqichlariga ixtisoslashgan bo'lib, cheklangan narx belgilash imkoniyatiga ega. Kompaniyaning bozor kapitalizatsiyasi barcha chiqarilgan qimmatli qog'ozlarning umumiy qiymatini aks ettirib, global pul oqimlari dinamikasini qamrab oladi. Ushbu ko'rsatkich biznesning bozor qiymatini investorlar kutganlari prizmasi orqali o'lchaydi. Grafik tahlili hamkorlar to'lovlariga bog'liqlikni hisobga olgan holda risklarning qayta baholanishini kuzatish imkonini beradi. Narx belgilash imkoniyatining zaifligi biznesni keskin korreksiyalarga nisbatan zaif qiladi.
Muhim raqobatchilar
Bozor kapitallashuvi ARGX (argenx)|Bozor kapitallashuvi BioNTech Inc.|Abivax S.A. - Bozor kapitallashuvi|Bozor qiymati ADMA Corp|Protagonist Therapeutics (PTGX) - Bozor qiymati|Bozor kapitallashuvi IMVT|Bozor qiymati Kiniksa|Grifols SA - Bozor bahosi|Bozor kapitallashuvi ADPT|CLDX (Celldex Corp) - Bozor qiymati|Bozor kapitallashuvi AUPH (Aurinia Pharmaceuticals)|Bozor kapitallashuvi biocryst.com BCRX|VERA - Bozor qiymati|Bozor qiymati DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Bozor qiymati|Bozor bahosi AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Bozor kapitallashuvi|Bozor kapitallashuvi precigen.com|Bozor bahosi PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Bozor qiymati|Bozor kapitallashuvi UPB (Upstream Bio Corp)|Bozor kapitallashuvi Zenas Corp (ZBIO)|IMNM - Bozor qiymati|gossamerbio.com (GOSS) - Bozor bahosi|KalVista Pharmaceuticals, Inc. (KALV) - Bozor qiymati|Bozor bahosi Septerna, Inc.|Bozor bahosi PVLA|Bozor kapitallashuvi Savara Pharma|Bozor qiymati Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Bozor kapitallashuvi|Bozor kapitallashuvi ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Bozor qiymati|RAPT Therapeutics - Bozor kapitallashuvi|JBIO - Bozor kapitallashuvi|ACRS: Bozor kapitallashuvi|Bozor kapitallashuvi kyvernatx.com KYTX|TLSA (Tiziana Life Sciences Ltd) - Bozor kapitallashuvi|Bozor qiymati Cabaletta Bio Inc. CABA|Bozor qiymati Ventyx Bio (VTYX)|Theratechnologies, Inc - Bozor kapitallashuvi|Avalo Therapeutics, Inc - Bozor bahosi|Bozor kapitallashuvi eledon.com ELDN|CLYM - Bozor qiymati|Bozor kapitallashuvi zurabio.com ZURA|ATYR: Bozor kapitallashuvi|Adagene Inc. (ADAG) - Bozor kapitallashuvi|IMA (ImageneBio) - Bozor kapitallashuvi|STTK - Bozor kapitallashuvi|Bozor kapitallashuvi EQ|CNTB - Bozor qiymati|Bozor qiymati Immunic IMUX|ATRA: Bozor kapitallashuvi|IFRX - Bozor qiymati|Bozor bahosi XFOR|ACET: Bozor kapitallashuvi|Celularity - Bozor qiymati|INMB (INmune Bio Corp) - Bozor kapitallashuvi|Bozor kapitallashuvi Barinthus Biotherapeutics Corp|Bozor qiymati Kezar Life Sciences (KZR)|SABS (sabbiotherapeutics.com) - Bozor qiymati|Bozor qiymati Akari Therapeutics Plc AKTX|ENLV - Bozor bahosi|Q32 Bio Corp - Bozor kapitallashuvi|GOVX - Bozor kapitallashuvi|EDSA (Edesa Biotech, Inc.) - Bozor bahosi|ibioinc.com - Bozor qiymati|CARM (Carisma Therapeutics Inc) - Bozor kapitallashuvi|XTL Biopharmaceuticals Ltd (XTLB) - Bozor kapitallashuvi|Bozor qiymati Bolt Biotherapeutics (BOLT)|Bozor bahosi hcwbiologics.com HCWB|Bozor qiymati Aptevo Therapeutics Inc. APVO|AIM - Bozor bahosi|ADTX: Bozor bahosi|GRI - Bozor kapitallashuvi|XORTX (XRTX) - Bozor qiymati|Bozor kapitallashuvi HIND|REVB (Revelation Biosciences) - Bozor kapitallashuvi|Bozor qiymati indaptusrx.com INDP|Bozor kapitallashuvi SCNI|Bozor kapitallashuvi calcimedica.com (CALI)|Bozor kapitallashuvi AFMD (Affimed N.V.)|Bozor kapitallashuvi Allakos Inc|HOOKIPA - Bozor kapitallashuvi|Bozor qiymati IGM Biosciences, Inc.|iTeos Therapeutics, Inc. (ITOS) - Bozor qiymati|Bozor kapitallashuvi OCEA|Bozor bahosi TCBP|Bozor kapitallashuvi Third Harmonic Bio Inc
